Table 1. The demographic and clinical characteristics of the patients and controls.
| Patients n=42 | Controls n=44 | |
|---|---|---|
| Age (year) (mean/±SD) | 38.12 (±8.96) | 37.3 (±8.9) |
| Female gender (n/%) | 27 (64.3%) | 25 (56.8%) |
| BMI (kg/m2) (median/range) | 25.8 (19.11) | 21.59 (10.46) |
| Irisin (ng/mL) (median/range) | 8.21 (64.45) | 14.98 (97.45) |
| Nesfatin-1 (ng/mL) (median/range) | 5.90 (48.01) | 19.65 (88.29) |
| EDSS (median/range) | 1.5 (5.50) | |
| MS duration (year) (median/range) | 7.0 (25.0) | |
| MS relapse number* (median/range) | 4.0 (9.0) |
SD: standard deviation; BMI: body mass index; EDSS: Expanded Disability Status Scale; MS: multiple sclerosis. *Number of all relapses since diagnosis.